Good Luck investors. Don't be surprise if we see a 10% POP. Do your DD.
Hang on for the ride. :-)
Good Luck. Do your DD.
Sentiment: Strong Buy
Many Thanks CEO Jeff Meckler. Both 28th Annual ROTH Conference
On Mar. 14th at the Ritz-Carlton Laguna Niguel Hotel in Dana Point, Ca.
and at the Barclays Capital Global Healthcare Conference is all, I wanted,
and probably other investors, wanted to hear that you're getting the word
out on your recent developments. Again, many thanks.
A Long term investor.
Wow, has anyone seen the COCP presentation - Antiviral Therapies? Amazing that COCP is the only company with Drug Resistant Crystals according to the presentation. Also, their Drug-resistant crystal pipeline developed. Finally, that their Technology Platform Focuses on Viral Replication
Drug Targets Through Cocrystalization. For all investors, do your DD. Nonetheless, in my opinion, COCP is a safe bet going forward with it's Technology platform developing new Drug. Please go to their website for more info.
At some point, COCP management needs to create share holder value going forward. Get some information out concerning developments. Thanks.
Well, 20 day moving avg, has crossed the 50 day moving avg. and this is way the stock price starts it's upward momentum. It will be slow, but note, going forward it UP from this point. :-) Good luck
Sentiment: Strong Buy
I guess the News is that the market had factored in the Williams deal into the price, and now the rumor is that the buyout deal is not happening, as a result, ETE stock price should pop. Not sure about the 25%, but should be big, if the rumor is true. note, I believe it's ONLY rumor concerning the cancelled merger. I'm still long. BTW, I received a very nice dividend the other day from ETE. :-)
Note, UUUU is about to pop, when 20 day moving average line crosses the 50 day moving average line. And, this is about to happen if stock price remains above $2.20. (2/24/16). Good Luck and wait for the ride up. :-)
Do you DD. Buy, buy, buy..... . :-)
Do your dd. Good luck investing.
What the heck is going on?
As you know, next game changer is it's glycoengineered monoclonal antibody. And, we have a winner especially with fast track approval process going forward and being pulled by USG. :-)
Holding for long term.